home About Us People Portfolio News Contact Us Fund II Investor Login » Fund III Investor Login » Fund IV Investor Login »

news

Nov29
2016
Tandem Diabetes Care to Draw Down $35 Million under Existing Term Loan Facility with CRG »


SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) today announced that it has initiated the drawdown of $35 million under the company’s previously announced term loan facility with Capital Royalty Partners II L.P. and its affiliated funds ("CRG"). The transfer of funds is scheduled to take place by December 31, 2016.

 

“Our access to CRG’s debt facility as part of our overall financing strategy has allowed us to invest in commercialization and research and development efforts to become the fastest growing insulin pump company in the United States,” said Kim Blickenstaff, Tandem’s President and Chief Executive Officer. “We value…

Read More »

Oct28
2016
Omeros Announces $125 Million New Credit Facility »


Houston, Oct. 28, 2016 -- Omeros Corporation  (NASDAQ: OMER) today announced that it has entered into a senior credit facility with  CRG LP, a healthcare-focused investment firm, to retire the company’s existing credit facility, minimizing restricted cash requirements and providing additional working capital for its advancing pipeline.

The new credit facility consists of an $80 million  term loan to be drawn by the company within ten business days and the ability, subject to the satisfaction of certain conditions to access additional funding of up to an aggregate of $45 million  in two tranches through  December 31, 2017.…

Read More »

Oct19
2016
CRG Appoints Adam Whitehead as Vice President of Investor Relations »


Houston, Oct. 19, 2016 -- CRG, a global healthcare-focused investment firm supporting innovative healthcare companies, announced today the appointment of Adam Whitehead as Vice President of Investor Relations in the firm's Boulder office. Mr. Whitehead will help build and manage relationships with CRG's limited partners and expand the firm's investor relations strategy. Mr. Whitehead will report to Mike Weinmann, Managing Director at CRG.

Mr. Whitehead brings to CRG more than 10 years of experience in asset allocation, manager due diligence and fundraising, and established relationships with institutional investors. Previously, Mr. Whitehead spent six years as a senior investment analyst at Crestone Capital…

Read More »

Oct18
2016
CRG Provides Investment Update, Committing $458 Million to New Healthcare Investments in 2016 »


Houston, Oct. 18, 2016 -- CRG, a global healthcare-focused investment firm supporting innovative healthcare companies, today announced cumulative financing commitments of $458 million across eight public and private, commercial-stage healthcare companies since the beginning of 2016.

 

"Over the last 12 months, we have continued to experience a significant uptick in financing activity with cumulative commitments of over $650 million," said Nate Hukill, President of CRG. "Additionally, we have deployed more than $2.0 billion to public and private commercial-stage healthcare companies since 2009, generating attractive risk-adjusted returns for our institutional partners. This momentum is a testament to the investment team's…

Read More »

Sep8
2016
Specialists On Call, Inc. Raises $50 Million in Capital »


Financing to Accelerate Growth of the Business Through Investments and Acquisitions 

 

Reston, VA – September 8, 2016 – Specialists On Call, Inc. (“SOC”), the nation’s leading provider of clinical telemedicine services to acute care hospitals, today announced that it has raised $50 million in new capital through a combination of equity and a credit facility from CRG, a healthcare-focused investment firm delivering pioneering growth capital solutions to the global healthcare market. SOC intends to use the funds to accelerate its robust organic growth and actively pursue strategic acquisition opportunities.

 

"We are pleased to have the support of our…

Read More »

Jun29
2016
Iroko Pharmaceuticals Secures Debt Financing From CRG »


PHILADELPHIA - June 29, 2016 - PRNewswire -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company has entered into a $140 million debt facility agreement with CRG LP to retire an existing debt facility and provide additional working capital for the company.

 

"We are very pleased to enter into this agreement with CRG, an investment partner known for its strategic investments in healthcare," said Osagie Imasogie, Executive Chairman and CEO of Iroko.  "This financing will assist us in fulfilling our mission of making available Iroko's low-dose SoluMatrix®NSAIDs to…

Read More »

Jun15
2016
Avinger, Inc. Announces Drawdown of $10 Million Under Term Loan Facility with CRG »


--- Additional funding to support commercialization of Pantheris™ ---
 

REDWOOD CITY, Calif., June 15, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that it has completed its second drawdown under the previously announced term loan facility with CRG LP (formerly known as Capital Royalty) and its affiliate funds ("CRG") for proceeds of $10 million before closing fees. The term loan facility gives the Company access to borrow up to $50 million, inclusive of the initial draw of $30 million in September 2015 and this tranche of…

Read More »

Jun14
2016
Cardiome Announces Term Loan Agreement with CRG-Managed Funds »


VANCOUVER, Canada, June 14, 2016 -- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ("Cardiome" or the "Company") today announced that it has entered into a term loan agreement (the "Agreement") with CRG-managed funds. The Agreement provides Cardiome with up to $30 million of available borrowing capacity.

 

Under the terms of the Agreement, CRG and its managed funds will initially provide $20 million which will be used to retire existing debt and for general working capital purposes. Up to $10 million of additional funding will be available to Cardiome in two tranches, through June 2017, subject…

Read More »

May25
2016
CRG Promotes David Carter to Managing Director »


Houston, TX - May 25, 2016 – CRG, a healthcare-focused investment firm delivering pioneering growth capital solutions to the global healthcare market, announced today that David Carter has been promoted to Managing Director.

 

Mr. Carter joined the firm in 2003 and previously served as a Principal. Mr. Carter’s responsibilities include identifying, structuring, and leading due diligence related to new financing transactions, monitoring existing investments, and managing the firm’s junior investment team members. During his tenure at CRG, Mr. Carter has been directly involved in over 30 investments, representing more than $1.5 billion of committed capital.

 

“David’s diligence expertise…

Read More »

Feb1
2016
CRG Fund II Closes $167 Million Term Loan Securitization »


-- Financing Receives A- Rating by the Kroll Bond Rating Agency --

 

NEW YORK, NY, February 1, 2016 – CRG, a healthcare-focused investment firm delivering pioneering growth capital solutions to the global healthcare market, announced today that it closed on a $167 million term loan securitization on behalf of Capital Royalty Partners II, L.P. and certain of its parallel investment vehicles (“CRG II”, or the “Fund”).  The transaction was effective on January 15, 2016.
 
The securitization transaction – or Asset-Backed Securities (“ABS”) financing – is the first securitization completed by CRG and represents a significant milestone…

Read More »

Jan18
2016
Autonomic Technologies Secures Financing from CRG »


January 18, 2016 – Autonomic Technologies, Inc. (“ATI”), a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache, secured expansion financing from CRG, a premier healthcare investment firm. ATI has developed the Pulsante™ SPG Microstimulator System to provide on-demand Sphenopalatine Ganglion (“SPG”) stimulation therapy with the intention to relieve the acute debilitating pain of cluster headache. Pulsante is a minimally-invasive, rechargeable, multi-channel, peripheral nerve stimulation system.

 

“We are pleased to have the support of CRG, an investment partner renowned for its strategic investments in healthcare,” said Gary Burbach, CEO of…

Read More »

Jan12
2016
Tandem Diabetes Care Amends Term Loan Facility with CRG »


Increased Borrowing Capacity to Provide Flexibility for Anticipated Growth

 

San Diego --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) today announced the amendment of its term loan facility with Capital Royalty Partners II, L.P. and its affiliate funds ("CRG"), which will provide the Company access to $50 million in addition to the $30 million borrowed from CRG in January 2013. Under the terms of the amended agreement, Tandem is required to draw $15 million in January 2016 and has a one-time option to access up to an additional $35 million on or before December 31, 2016. The…

Read More »